Akili, Inc. launched EndeavorOTC, a video game therapy for attention deficit/hyperactivity disorder (ADHD) in adults, at the inaugural Digital Therapeutics Alliance Summit in Washington, DC on 7 June.
EndeavorOTC is based on the same technology as Akili's EndeavorRx therapy for children. The US Food and Drug Administration authorized EndeavorRx in 2020 to treat symptoms of ADHD in children 8-12, making it the first FDA-cleared game-based device